Search

everythinglearnresearchcommunity

for

Search:↓

Patients with multiple superficial venous thrombosis are at greater risk for serious complications like cancer and recurrent blood clots.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

Using hemocoagulase with platelet-rich plasma in hip replacement can lessen blood loss and improve healing and blood clotting.

PRS injections can improve knee function and reduce pain for up to a year.

A few users dominate Reddit discussions on JAK inhibitors, highlighting social media's potential for tracking drug safety but needing expert oversight.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Injecting Platelet-Rich Plasma reduces leakage risk in colorectal surgery.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Citrate is a safer alternative to heparin for preventing blood clots in hemodialysis.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

miR-150 helps blood vessel cells develop and speeds up blood clot healing.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Intravenous and oral calcium effectively treated vitamin D dependent rickets type II, improving growth and bone health.